This Detroit Auto Stock Has Soared, but There's Still One Nagging Problem: China

The market is likely underpricing how a “non-core” China drag can cap GM’s multiple even if U.S. truck cash flow stays intact. The key mechanism is not just lost units; it is recurring impairment risk, management distraction, and a persistent discount on capital allocation because buybacks/dividends are being funded by a business with unresolved write-down overhang. In the next 1-3 months, the stock can still trade on North America margins, but any further China charge or weak commentary should compress the valuation gap versus F and STLA quickly.

The 2027 JV expiration is the real catalyst window. That creates a binary path: either GM renegotiates into a more capital-light, export-oriented structure, or it effectively crystallizes China as a trapped asset with limited strategic value. The second-order effect is that suppliers, software partners, and local EV initiatives get less of a long-duration revenue stream, so the upside from “revival” is probably less than investors assume unless GM can prove a locally differentiated premium product cycle.

Contrarian view: the consensus may be too focused on China unit weakness as cyclical when it is actually strategic. If GM’s U.S. margins hold, the headline P/L hit may look manageable, but the hidden risk is that every incremental dollar of capital returned to shareholders competes with an unproductive overseas asset base, limiting reinvestment optionality. Falsifier: two straight quarters of stable China sales or no further restructuring charges by the next earnings cycle would argue the thesis is overdone; otherwise the 6-18 month drift is toward more write-offs and lower multiple support.